Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes

• US 5,260,050 A
• Filed: 01/11/1990
• Issued: 11/09/1993
• Est. Priority Date: 09/29/1988
• Status: Expired due to Fees

• Current Assignee: Access Pharmaceuticals Inc.
• Original Assignee: David F. Ranney
• Inventors: Ranney, David F.
• Primary Examiner(s): Hollrah, Glennon H.
• Assistant Examiner(s): Hollinden, Gary E.
• Application Number:
  US07/463,692
• Time in Patent Office: 1,398 Days
• Field of Search: 424/9, 424/617, 424/646, 424/2, 436/173, 436/806, 128/653.4, 128/654, 556/61, 536/102, 536/112, 536/122
• US Class Current: 424/9.351
• CPC Class Codes: A61K 47/61 the organic macromolecular compound being a polysaccharide or a derivative thereof
• CPC Class Codes: A61K 47/6939 the polymer being a polysaccharide, e.g. starch, chitosan, chitin, cellulose or pectin
• CPC Class Codes: A61K 49/085 conjugated systems
• CPC Class Codes: A61K 49/128 comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
• CPC Class Codes: A61K 49/1863 the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
• CPC Class Codes: G01R 33/5601 involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
• CPC Class Codes: Y10S 436/806 Electrical property or magnetic property
• CPC Class Codes: Y10S 977/705 Protein or peptide
• CPC Class Codes: Y10T 436/24 Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Abstract

Improved compositions and methods for selective access to tumor regions (or other regions of abnormal endothelial properties). This capability provides powerful contrast-enhancement agents for nuclear magnetic resonance imaging. A polyatomic complex which includes intramolecular ferromagnetic coupling between metal atoms is associated with a polymer or microsphere carrier matrix which will bind to endothelial determinants. A solution containing this carrier complex is injected into a human (or other) body to be imaged. The carrier complex will preferentially extravasate at locations where the blood vessel walls have increased porosity or microvascular surface changes, and especially at tumor sites. Thus, the changes in relaxation time induced by the presence of the carrier complex will provide a high-gain marker for magnetic resonance imaging.

Multiple superparamagnetic polyatomic complexes are described, including novel complexes which include acetate and glycinate bridging ligands with a polyatomic metal-atom-complex core.

Claims

1. A composition of matter comprising

a superparamagnetic polyatomic metal atom complex, containing plural paramagnetic metal atoms which are intramolecularly ferromagnetically coupled, and including bridging ligands bound to said paramagnetic metal atoms, said polyatomic metal complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands,

said polyatomic complex being bound to or associated with:

a biocompatible and at least substantially water-soluble anionic carbohydrate, oligosaccharide, polysaccharide, or glycosaminoglycan carrier;

said carrier having repeating hydrophilic units which contain covalently bound available reactive groups selected from the group consisting of hydroxyl, carbonyl, aldehyde, carboxylate, sulfate, phosphate and amine groups,

wherein said polyatomic metal atom complex is in a molar ratio to individual repeating units of said carrier of between about 1;

2 and about 1;

25.

2. The composition of claim 1 defined further, wherein said carrier is complementary to determinants of vertebrate endothelia or epithelia.

3. The composition of claim 1, defined further as an in vivo diagnostic agent for enhancing internal images or shifting internal spectra arising from induced magnetic resonance signals.

4. The composition of claim 1, wherein said carrier has a molecular weight between about 1,000 and about 200,000 Daltons.

5. The composition of claim 1, wherein said carrier has a molecular weight between about 15,000 and about 45,000 Daltons.

6. The composition of claim 1, wherein said polyatomic metal atom complex is bound to said carrier noncovalently by a strong ionic, paired-ion or charge interaction.

7. The composition of claim 6, wherein said strong interaction is by chemical coordination or chelation binding of said polyatomic metal atom complex to one or more of said reactive groups of said polymer, each site of said coordination or chelation binding, on said carrier, having a coordination number or ionic charge number of between 2 and 10 inclusive.

8. The composition of claim 1, wherein said polyatomic metal atom complex is covalently conjugated to said carrier.

9. The composition of claim 8, wherein said covalent conjugation of said polyatomic metal atom complex to said carrier is by a metal-oxide bond or a direct metal bond to said carrier.

10. The composition of claim 1, wherein said carrier has a molecular size of less than about twelve nanometers, and said carrier contains less than about 5% (w/w) cross-linked or microaggregated species.

11. The composition of claim 1 wherein said water-soluble carrier is dextran, dextran sulfate, carboxymethyl dextran, dicarboxyethyl dextran, succinylated dextran, diethylenetriaminepentaacetate-dextran, dicarboxyethylhydroxyethyl starch, carboxymethylhydroxyethyl starch, succinylated hydroxyethyl starch, diethylenetriamine pentaacetate-starch, heparin, heparan sulfate, dermatan sulfate, pentosan polysulfate, dicarboxyethyl heparin, a heparin fragment, succinylated heparin, or diethylenetriaminepentaacetate-heparin.

12. The composition of claim 1, wherein said bridging ligands are acetate groups and said polyatomic metal atom complex consists essentially of Cr₄ S(O₂ CCH₃)₈ (H₂ O)₄⁺².

13. The composition of claim 1, wherein said polyatomic metal atom complex has the formula (Cr₄ SR_n C_m), where R is a bridging ligand of formate, formaldehyde, glutaraldehyde, acetate, glycinate, succinate, acetylacetonate, malonate, propionate, glutarate, hydroxamate, oxalate, 2-bromoacetate, 2-sulfoethanoate, thiolacetate or thioglycolate;

n is the number of R groups per metal atom complex, numbering between 4 and 12;

C is a stabilizing counterion selected from the group consisting of water, halide, sulfate, nitrate, carboxylate, and phosphate; and

m is between 1 and 2n.

14. The composition of claim 13 defined further, wherein said bridging is a combination of acetate and glycinate groups at a molar ratio of between about 1 and about 3 glycinates per polyatomic complex and amino groups of said glycinate assist in binding said polyatomic complex to said carrier.

15. The composition of claim 1, wherein said carrier consists essentially of heparin, or a heparin fragment.

16. The composition of claim 1, wherein said carrier has a molecular weight of between 15,000 and 26,000 Daltons.

17. The composition of claim 1, wherein said polyatomic metal atom complex is Cr₄ S(O₂ CCH₃)₈, and said carrier consists essentially of dextran, carboxymethyl dextran, dicarboxyethyldextran, succinylated dextran, diethylenetriamine pentaacetate-dextran or dextran sulfate.

18. The composition of claim 1, wherein said polyatomic metal atom complex is Cr₄ S(O₂ CCH₃)₈, and said carrier consists essentially of hydroxyethyl starch, carboxymethyl hydroxyethyl starch, dicarboxyethyl hydroxyethyl starch, succinylated hydroxyethyl starch or diethylenetriamine pentaacetate-starch.

19. The composition of claim 2, wherein said polyatomic metal atom complex is Cr₄ S(O₂ CCH₃)₈, and said carrier consists essentially of heparin, dicarboxyethyl heparin, carboxymethyl heparin, succinylated heparin or diethylenetriamine pentaacetate-heparin.

20. The composition of claim 1, wherein said polyatomic metal atom complex and said carrier are formulated as microspheres with a diameter between 0.1 micrometers and about 250 micrometers.

21. The composition of claim 20, wherein said microspheres have a diameter between about 0.1 micrometer and about 4.0 micrometers, and said polyatomic metal atom cluster consists essentially of (Cr₄ S(O₂ CCH₃)₈ (H₂ O)₄)⁺² bound to diethylenetriamine pentaacetate-dextran, diethylenetriamine pentaacetate-hydroxyethyl starch, heparin, dextran sulfate or pentosan polysulfate.

22. A method for magnetic resonance imaging, comprising the steps of:

identifying a living vertebrate animal to be imaged;

introducing into the blood stream or body cavity of said animal a diagnostically effective amount of a diagnostic imaging agent comprising an at least substantially water-soluble anionic carrier with a molecular weight of greater than about 1,000 Daltons, and also includes plural superparamagnetic polyatomic metal atom complexes associated with said carrier, each of polyatomic metal atom complexes including plural paramagnetic metal atoms which are intramolecularly ferromagnetically coupled metal, said polyatomic metal complexes consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands;

applying to said animal a strong magnetic field which includes a gradient; and

applying to at least a portion of said animal an electromagnetic perturbation field at a radio frequency corresponding to a resonant frequency of a predetermined atomic nucleus at a magnetic field strength which falls within a range of field strengths applied to said animal by said strong magnetic field, and measuring radio frequency emissions to define a spatial map of magnetic resonance characteristics within tissues of said animal.

23. The method of claim 22, wherein said carrier molecule has a molecular weight of about 15,000 to 45,000 Daltons.

24. The method of claim 22, wherein said carrier consists essentially of heparin or a heparin fragment.

25. The method of claim 22, wherein said carrier consists essentially of heparin, or a heparin fragment, and the size of said polymeric compound is less than about twelve nanometers, and said superparamagnetic polyatomic complex consists essentially of Cr₄ S(O₂ CCH₃)₈ (H₂ O)₄⁺².

26. The method of claim 22, wherein said superparamagnetic polyatomic complex consists essentially of Cr₄ S(O₂ CCH₃)₈ (H₂ O)₄⁺².

27. A composition of matter comprising

a superparamagnetic polyatomic metal atom complex, containing plural paramagnetic metal atoms which are intramolecularly ferromagnetically coupled, and including bridging ligands bound to said paramagnetic metal atoms, said polyatomic metal complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands,

said polyatomic complex being bound to or associated with:

a biocompatible and at least substantially water-soluble anionic carbohydrate, oligosaccharide, polysaccharide, or glycosaminoglycan carrier;

said carrier having repeating hydrophilic units which contain covalently bound available reactive groups selected from the group consisting of hydroxyl, carbonyl, aldehyde, carboxylate, sulfate, phosphate and amine groups, wherein said carrier is complementary to determinants of vertebrate endothelia or epithelia,

wherein said polyatomic metal atom complex is in a molar ratio to individual repeating units of said carrier of between about 1;

2 and about 1;

25.

28. A composition of matter comprising

a superparamagnetic polyatomic metal atom complex, containing plural paramagnetic metal atoms which are intramolecularly ferromagnetically coupled, and including bridging ligands bound to said paramagnetic metal atoms, said polyatomic metal complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands,

said polyatomic complex being bound to or associated with:

a biocompatible and at least substantially water-soluble carbohydrate, oligosaccharide, polysaccharide, or glycosaminoglycan carrier;

said carrier having repeating hydrophilic units which contain covalently bound available reactive carboxylate or sulfate groups,

wherein said polyatomic metal atom complex is in a molar ratio to individual repeating units of said carrier of between about 1;

2 and about 1;

25.

29. A composition of matter comprising

a superparamagnetic polyatomic metal atom complex, containing plural paramagnetic metal atoms which are intramolecularly ferromagnetically coupled, and including bridging ligands bound to said paramagnetic metal atoms, said polyatomic metal complex consisting essentially of four Cr(III) atoms which are bound to a central tetrahedral sulfur atom and are octahedrally coordinated by bridging ligands,

said polyatomic complex being bound to or associated with:

a biocompatible and at least substantially water-soluble carbohydrate, oligosaccharide, polysaccharide, or glycosaminoglycan carrier;

said carrier having repeating hydrophilic units which contain covalently bound available reactive groups selected from the group consisting of carboxylate and sulfate, wherein said carrier is complementary to determinants of vertebrate endothelia or epithelia,

wherein said polyatomic metal atom complex is in a molar ratio to individual repeating units of said carrier of between about 1;

2 and about 1;

25.